Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0210
-0.0048 (-18.60%)
Sep 11, 2025, 3:56 PM EDT
Regen BioPharma Employees
Regen BioPharma had 1 employees as of September 30, 2024. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$236,561
Profits / Employee
-$1,171,778
Market Cap
865.71K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 1 | 0 | - |
| Sep 30, 2023 | 1 | 0 | - |
| Sep 30, 2022 | 1 | -3 | -75.00% |
| Sep 30, 2018 | 4 | 0 | - |
| Sep 30, 2017 | 4 | 0 | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Regen BioPharma News
- 2 months ago - Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc. - Accesswire
- 10 months ago - Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™ - GlobeNewsWire
- 1 year ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time - GlobeNewsWire
- 1 year ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024 - PRNewsWire
- 1 year ago - Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024 - PRNewsWire
- 1 year ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024 - PRNewsWire
- 1 year ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024 - PRNewsWire
- 1 year ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024 - PRNewsWire